Quantbot Technologies LP - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$552,258
+0.8%
10,602
+22.5%
0.04%
+2.8%
Q2 2023$548,098
-5.4%
8,656
-19.1%
0.04%
-12.2%
Q1 2023$579,080
+952.9%
10,694
+799.4%
0.04%
+925.0%
Q3 2022$55,000
-90.9%
1,189
-89.7%
0.00%
-91.8%
Q4 2021$604,000
+1625.7%
11,554
+730.6%
0.05%
+1125.0%
Q3 2020$35,000
-64.3%
1,391
-89.4%
0.00%
-60.0%
Q3 2019$98,000
+1300.0%
13,174
+1845.9%
0.01%
+900.0%
Q4 2018$7,000
-93.0%
677
-85.3%
0.00%
-85.7%
Q3 2018$100,000
+9900.0%
4,609
+5520.7%
0.01%
Q2 2018$1,000
-99.2%
82
-98.6%
0.00%
-100.0%
Q1 2018$119,000
+133.3%
5,698
+61.2%
0.01%
+100.0%
Q4 2017$51,000
-62.2%
3,534
-59.0%
0.01%
-61.5%
Q3 2017$135,000
+321.9%
8,614
+233.1%
0.01%
+333.3%
Q2 2017$32,000
-44.8%
2,586
-33.1%
0.00%
-50.0%
Q4 2016$58,000
+141.7%
3,864
+527.3%
0.01%
+50.0%
Q3 2015$24,0006160.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders